Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
6
55%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(6)
Terminated(1)
Other(4)

Detailed Status

Completed6
unknown4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
85.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

terminated19%
unknown436%
completed655%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DEVICE
Total Trials
11